Vident Advisory’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.6M Buy
46,930
+7,575
+19% +$3.83M 0.18% 104
2025
Q4
$22.3M Sell
39,355
-598
-1% -$318K 0.2% 100
2025
Q3
$17.9M Buy
39,953
+10,466
+35% +$5.02M 0.17% 119
2025
Q2
$16M Buy
29,487
+16,567
+128% +$8.66M 0.18% 117
2025
Q1
$6.4M Buy
12,920
+3,948
+44% +$2.18M 0.09% 195
2024
Q4
$4.68M Buy
8,972
+904
+11% +$471K 0.08% 220
2024
Q3
$3.96M Buy
8,068
+595
+8% +$277K 0.1% 203
2024
Q2
$3.32M Buy
7,473
+307
+4% +$122K 0.09% 228
2024
Q1
$2.86M Buy
7,166
+637
+10% +$241K 0.06% 307
2023
Q4
$2.2M Buy
6,529
+502
+8% +$150K 0.06% 357
2023
Q3
$1.76M Buy
+6,027
New +$1.88M 0.05% 341

Other funds holding ISRG

Vident Advisory's ISRG Position: Q1 2026 in Review

Vident Advisory increased its Intuitive Surgical (ISRG) stake by 19% in Q1 2026, buying an estimated $3.83M and bringing the position to 46,930 shares worth $21.6M. The position accounts for 0.18% of the portfolio, ranked #104.

Vident Advisory first reported a position in ISRG in Q3 2023 and has held it in 11 quarters since. The position peaked at $22.3M in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Vident Advisory held 46,930 shares of Intuitive Surgical worth $21.6M as of Q1 2026.
  • Vident Advisory bought 7,575 Intuitive Surgical shares in Q1 2026, an estimated $3.83M.
  • Intuitive Surgical made up 0.18% of Vident Advisory's portfolio in Q1 2026, its #104 holding.
  • Vident Advisory first reported a position in Intuitive Surgical in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Intuitive Surgical position peaked at $22.3M in Q4 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.